Wave Life Sciences (WVE) Operating Expenses (2014 - 2026)

Wave Life Sciences' Operating Expenses history runs 13 years deep, the most recent figure standing at $69.5 million for Q1 2026.

• Quarterly Operating Expenses rose 17.91% year-over-year to $69.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $268.7 million (up 16.47% YoY) and the FY2025 annual result came in at $258.1 million, up 18.02% from the prior year.
• Operating Expenses was $69.5 million for Q1 2026 at Wave Life Sciences, down from $73.7 million in the prior quarter.
• Across five years, Operating Expenses topped out at $73.7 million in Q4 2025 and bottomed at $39.2 million in Q3 2022.
• A 5-year average of $52.6 million and a median of $47.7 million in 2023 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2022 — Operating Expenses retreated 11.01% — and 2024, when it gained 27.32%.
• Wave Life Sciences' Operating Expenses stood at $44.8 million in 2022, then grew by 6.55% to $47.7 million in 2023, then rose by 27.32% to $60.8 million in 2024, then climbed by 21.27% to $73.7 million in 2025, then declined by 5.65% to $69.5 million in 2026.
• Business Quant data shows WVE's Operating Expenses at $69.5 million in Q1 2026, $73.7 million in Q4 2025, and $64.0 million in Q3 2025.